Last reviewed · How we verify

SODIUM SULFATE

FDA-approved approved Small molecule Under review Quality 20/100

SODIUM SULFATE is a drug. It is currently FDA-approved (first approved 1984) for Migraine headache pain, Headache pain with nausea, Headache due to simple nervous tension.

Sodium sulfate is a small molecule with a laxative mechanism. It has been studied in clinical trials for various conditions, including traumatic brain injury and dental plaque, but its primary use is not related to these conditions.

At a glance

Generic nameSODIUM SULFATE
ModalitySmall molecule
PhaseFDA-approved
First approval1984

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about SODIUM SULFATE

What is SODIUM SULFATE?

SODIUM SULFATE is a Small molecule drug, indicated for Migraine headache pain, Headache pain with nausea, Headache due to simple nervous tension.

What is SODIUM SULFATE used for?

SODIUM SULFATE is indicated for Migraine headache pain, Headache pain with nausea, Headache due to simple nervous tension.

When was SODIUM SULFATE approved?

SODIUM SULFATE was first approved on 1984.

What development phase is SODIUM SULFATE in?

SODIUM SULFATE is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing